Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes

Clinical trial NCT07167693 · RECRUITING

Trial details

NCT number: NCT07167693
Sponsor: David K Carroll
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetes (DM)Diabetic Ketoacidosis Ketosis Prone Diabetes Hyperglycaemia (Diabetic)

Start date: 2025-12-19
Primary completion: 2027-10-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.